(Q40459445)

20 September 2017

1 reference

title

Neuroblastoma stage IV-S. (English)

1 reference

20 September 2017

1 reference

T D Miale

1

1 reference

20 September 2017

K Kirpekar

series ordinal

2

1 reference

20 September 2017

publication date

1 January 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

11

1 reference

20 September 2017

issue

3-4

1 reference

20 September 2017

page(s)

89-100

1 reference

Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma

20 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02999856

Induction of neurite formation in PC12 cells by microinjection of proto-oncogenic Ha-ras protein preincubated with guanosine-5'-O-(3-thiotriphosphate).

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02999856

Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma

21 January 2018

1 reference

12 December 2020

The diagnostic and prognostic value of pretreatment serum creatine kinase BB levels in patients with neuroblastoma

1 reference

12 December 2020

Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group

1 reference

12 December 2020

Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21

1 reference

12 December 2020

Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis

1 reference

12 December 2020

Neuroblastoma. Mass screening for early detection and its prognosis

1 reference

12 December 2020

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene

1 reference

12 December 2020

Neuroblastoma: the result of multistep transformation?

1 reference

12 December 2020

Immunotherapy. Neuroblastoma as a model

1 reference

12 December 2020

Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.

1 reference

12 December 2020

Expression of a multidrug-resistance gene in human tumors and tissues

1 reference

12 December 2020

Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators

1 reference

12 December 2020

Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma

1 reference

12 December 2020

Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.

1 reference

12 December 2020

A review of 17 IV-S neuroblastoma patients at the children's hospital of philadelphia

1 reference

12 December 2020

1 reference

12 December 2020

Human newborns are deficient in natural killer activity

1 reference

12 December 2020

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

1 reference

12 December 2020

Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma

1 reference

12 December 2020

Improvement in prognosis of neuroblastoma through mass population screening

1 reference

12 December 2020

Staging systems in neuroblastoma: which is best?

1 reference

12 December 2020

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

1 reference

12 December 2020

Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia.

1 reference

12 December 2020

N-myc genomic content and DNA ploidy in stage IVS neuroblastoma

1 reference

12 December 2020

Expression of nerve growth factor receptor mRNAs and clinical response to retinoic acid in neuroblastoma

1 reference

12 December 2020

Mass screening for neuroblastoma and estimation of costs

1 reference

12 December 2020

P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma

1 reference

12 December 2020

Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.

1 reference

12 December 2020

ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma

1 reference

12 December 2020

Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells

1 reference

12 December 2020

IV-S neuroblastoma: a cooperative study of 30 children

1 reference

12 December 2020

Relapse from a stage IV-S neuroblastoma and N-myc amplification

1 reference

12 December 2020

Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group

1 reference

12 December 2020

Cytogenetic features of human neuroblastomas and cell lines.

1 reference

12 December 2020

Special pattern of widespread neuroblastoma with a favourable prognosis

1 reference

12 December 2020

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

1 reference

12 December 2020

Translocation (19;?) in two stage II neuroblastomas

1 reference

12 December 2020

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study

1 reference

12 December 2020

Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues

1 reference

12 December 2020

Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.

1 reference

12 December 2020

Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line

1 reference

12 December 2020

Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases

1 reference

12 December 2020

A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases

1 reference

12 December 2020

Intratumorous distribution of catecholaminergic clone cells of human neuroblastoma. A catecholamine fluorescence study

1 reference

12 December 2020

Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases

1 reference

12 December 2020

Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma

1 reference

12 December 2020

Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.

1 reference

12 December 2020

Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment

1 reference

12 December 2020

Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.

1 reference

12 December 2020

Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation

1 reference

12 December 2020

A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group

1 reference

12 December 2020

N-myc amplification in an infant with stage IVS neuroblastoma

1 reference

12 December 2020

Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group

1 reference

12 December 2020

The effects of gamma interferon on the natural killer and tumor cells of children with neuroblastoma. A preliminary report

1 reference

12 December 2020

HLA-A,B,C and beta 2-microglobulin are expressed weakly by human cells of neuronal origin, but can be induced in neuroblastoma cell lines by interferon

1 reference

12 December 2020

TRK-a expression in neuroblastomas: a new prognostic marker with biological and clinical significance

1 reference

12 December 2020

Sounding board. Regression of neuroblastoma IV-S: a genetic hypothesis

1 reference

12 December 2020

1 reference

12 December 2020

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

12 December 2020

Inverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastoma

1 reference

12 December 2020

Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies

1 reference

12 December 2020

Progression from stage IVS to stage IV neuroblastoma with eventual spontaneous resolution

1 reference

12 December 2020

A proposed staging for children with neuroblastoma.Children's cancer study group A

1 reference

12 December 2020

N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18).

1 reference

12 December 2020

Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes

1 reference

12 December 2020

The relationship of class I MHC antigen expression to stage IV-S disease and survival in neuroblastoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02999856

1 reference

Dimensions Publication ID

20 September 2017

1010372869

0 references

Fatcat ID

release_zeezuvwpujdd7ajkhxezjhw3ne

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zeezuvwpujdd7ajkhxezjhw3ne

24 November 2022

mapped directly with Wikidata item

1 reference